Cargando…

Analyzing the Factors Contributing to Withdrawal from Insulin Therapy Following Additional Administration of Alogliptin: Retrospective Study after Removing Glucotoxicity with Insulin

We attempted to examine whether withdrawal from insulin therapy is or is not possible with administration of additional alogliptin and identify the contributing factors. The subjects were 43 adult patients with type 2 diabetes undergoing insulin therapy after admission. After glucotoxicity was remov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamamoto, Hiromi, Nakanishi, Koji, Noda, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578556/ https://www.ncbi.nlm.nih.gov/pubmed/26441486 http://dx.doi.org/10.4137/JCM.S27202

Ejemplares similares

Body Weight Gain and Hyperphagia After Administration of SGLT-2 Inhibitor: A Case Report
por: Hamamoto, Hiromi, et al.
Publicado: (2015)

Which Factor Determines the Duration Required for Relief of Glucotoxicity by the Intensive Insulin Therapy?
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2012)

Lipid-Induced Adaptations of the Pancreatic Beta-Cell to Glucotoxic Conditions Sustain Insulin Secretion
por: Oberhauser, Lucie, et al.
Publicado: (2021)

Hexane Extract of Orthosiphon stamineus Induces Insulin Expression and Prevents Glucotoxicity in INS-1 Cells
por: Lee, Hae-Jung, et al.
Publicado: (2015)

Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Alogliptin: a new addition to the class of DPP-4 inhibitors
por: Andukuri, Radha, et al.
Publicado: (2009)

Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells
por: Katsura, Takashi, et al.
Publicado: (2017)

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
por: Kapoor, Shailendra
Publicado: (2012)

The ethyl acetate fraction of corn silk exhibits dual antioxidant and anti-glycation activities and protects insulin-secreting cells from glucotoxicity
por: Chang, Chia-Chuan, et al.
Publicado: (2016)

The role of membrane excitability in pancreatic β-cell glucotoxicity
por: Shyr, Zeenat A., et al.
Publicado: (2019)

Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes
por: Tonoike, Mie, et al.
Publicado: (2018)

Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study
por: Ihana, Noriko, et al.
Publicado: (2014)

Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)

Insulin Withdrawal in Diabetic Kidney Disease: What Are We Waiting for?
por: Morillas, Carlos, et al.
Publicado: (2021)

Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
por: Zheng, Hong, et al.
Publicado: (2016)

Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
por: Pignalosa, Francesca Chiara, et al.
Publicado: (2021)

Inhaled insulin: overview of a novel route of insulin administration
por: Mastrandrea, Lucy D
Publicado: (2010)

Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study
por: Nakanishi, Shuhei, et al.
Publicado: (2021)

The accuracy and precision of insulin administration using human and veterinary pen‐injectors and syringes for administration of insulin
por: Malerba, Eleonora, et al.
Publicado: (2021)

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
por: Noda, Yoko, et al.
Publicado: (2013)

Patient safety and minimizing risk with insulin administration – role of insulin degludec
por: Aye, Myint M, et al.
Publicado: (2014)

Intraperitoneal insulin administration in pigs: effect on circulating insulin and glucose levels
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2021)

Liquid Chromatographic Determination of Alogliptin in Bulk and in its Pharmaceutical Preparation
por: El-Bagary, Ramzia I., et al.
Publicado: (2012)

Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin
por: Yin, Hao, et al.
Publicado: (2013)

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2019)

Necrotizing Pancreatitis Secondary to Hydrochlorothiazide and Alogliptin: A Case Report
por: Del Rio, Teresa, et al.
Publicado: (2023)

Lin28a ameliorates glucotoxicity-induced β-cell dysfunction and apoptosis
por: Hwang, Yeo Jin, et al.
Publicado: (2021)

The glucotoxicity protecting effect of honokiol in human hepatocytes via directly activating AMPK
por: Liu, Hui, et al.
Publicado: (2022)

Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice
por: Ahrén, Bo
Publicado: (2023)

Hyperglycæmia Caused by Prolonged Administration of Insulin
por: Bose, J. P.
Publicado: (1949)

Hyperglycæmia Caused by Prolonged Administration of Insulin
Publicado: (1949)

Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation
por: Frank, N., et al.
Publicado: (2017)

Visceral Fat Accumulation, Insulin Resistance, and Elevated Depressive Symptoms in Middle-Aged Japanese Men
por: Yamamoto, Shuichiro, et al.
Publicado: (2016)

Increase in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Had a Strong Impact on the Development of Type 2 Diabetes in Japanese Individuals with Impaired Insulin Secretion: The Saku Study
por: Morimoto, Akiko, et al.
Publicado: (2014)

Microvascular Contributions to Insulin Resistance
por: Rattigan, Stephen, et al.
Publicado: (2013)

The contributions of insulin to science in medicine
por: Kurtzhals, Peter, et al.
Publicado: (2021)

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus
por: Ihana-Sugiyama, Noriko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rh09e9mi3j8rk5hpra45bgmdo5